ABT-594 dihydrochloride (Tebanicline dihydrochloride) is a potent analgesic agent with efficacy in models of acute, persistent chemical, and neuropathic pain; it exhibits significant antinociceptive effects against acute noxious thermal stimulation in mice and rats; it is orally active and acts primarily through central neuronal nicotinic acetylcholine receptors (nAChRs); direct injection into the nucleus raphe magnus (NRM) produces antinociception in thermal threshold tests.